Literature DB >> 7413663

Persistence of Pneumococcal antibodies in human subjects following vaccination.

P P Vella, A A McLean, A F Woodhour, R E Weibel, M R Hilleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7413663     DOI： 10.3181/00379727-164-40891

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

1.  Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination.

Authors:  C Kraus; S Fischer; R Ansorg; U Hüttemann
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

2.  Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.

Authors:  P P Vella; S Marburg; J M Staub; P J Kniskern; W Miller; A Hagopian; C Ip; R L Tolman; C M Rusk; L S Chupak
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

Review 3.  Capsular polysaccharide vaccines today.

Authors:  P H Mäkelä
Journal:  Infection       Date:  1984       Impact factor: 3.553

4.  Pneumococcal sepsis and meningitis in vaccinated subjects: a review of 55 reported cases.

Authors:  M H Zarrabi; F Rosner
Journal:  J Natl Med Assoc       Date:  1987-04       Impact factor: 1.798
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.